Universitätsklinikum Münster

Evaluation of INSTAND e.V.'s external quality assessment for Cryptococcus antigen testing autumn 2016-spring 2021 (2021) Wilmes D, Heckmann D, Ehrhard I, Schaumburg F, Dichtl K, Schoerner C, Mccormick-Smith I, Rickerts V Conference contribution Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution The Nectin-1 Expression correlates with the Susceptibility of malignant Melanoma to oncolytic Herpes Simplex Viruses in vitro and in vivo (2021) Schwertner B, Linder G, Stauner CT, Klapproth E, Magnus C, Rohrhofer A, Gross S, et al. Conference contribution IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome (2021) Gloss S, Jurmeister P, Thieme A, Schmid S, Cai WY, Serrette RN, Perner S, et al. Journal article CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021) Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al. Journal article Re-Irradiation in head & neck cancer - a pooled analysis of 253 individual cases (2021) Roesch J, Oertel M, Fabian A, Hoeck M, Von Der Gruen J, Loeser A, Suess C, et al. Conference contribution Fireside chat § 13 (2b) AMG in nuclear medicine therapy - A follow-up event of NuklearMedizin 2020 - Digital Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie - eine Follow-up-Veranstaltung der NuklearMedizin 2020 - Digital (2021) Patt M, Bengel F, Essler M, Krause BJ, Kuwert T, Rahbar K, Sabri O, et al. Journal article Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives (2021) Willems LM, Rosenow F, Schubert-Bast S, Kurlemann G, Zoellner JP, Bast T, Bertsche A, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases (2021) Zaremba A, Philip M, Hassel JC, Glutsch V, Fiocco Z, Loquai C, Rafei-Shamsabadi D, et al. Journal article